-
China Commercial Credit Inc (NASDAQ: CCCR)
dropped 14.8 percent to $2.41 after climbing 11.42 percent on Friday.
-
Great Basin Scientific Inc (NASDAQ: GBSN) shares
dipped 13.3 percent to $0.98 on Q1 results. Great Basin Scientific posted Q1 net income of $21,503,600, versus a year-ago net
loss of $33,652,500.
-
NetSol Technologies Inc. (NASDAQ: NTWK) fell 12.2
percent to $3.95. NetSol Technology posted Q3 earnings of $0.06 per share on sales of $17.9 million. The company also issued a
weak sales forecast for FY 2017.
-
Quorum Health Corp (NYSE: QHC) shares dropped 11.5
percent to $3.53.
-
Diana Containerships Inc (NASDAQ: DCIX) tumbled
8.3 percent to $0.431. Diana Containerships reported a Q1 loss of $0.80 per share on sales of $3.77 million.
-
National Grid plc (ADR) (NYSE: NGG) shares declined
7.7 percent to $69.41 after surging 10.50 percent on Friday.
-
Interpace Diagnostics Group Inc (NASDAQ: IDXG)
dropped 7.6 percent to $2.18 after the company filed for up to $13.8 million stock offering.
-
GlycoMimetics Inc (NASDAQ: GLYC) shares declined
7.1 percent to $11.86 after surging 19.59 percent on Friday.
-
Synchronoss Technologies, Inc. (NASDAQ: SNCR)
shares slipped 7 percent to $12.60. Credit Suisse downgraded Synchronoss Technologies from Neutral to Underperform.
-
Zoe's Kitchen Inc (NYSE: ZOES) dropped 6.7 percent
to $16.97. Baird downgraded Zoe's Kitchen from Outperform to Neutral.
-
Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) fell
5.6 percent to $14.68. Barclays downgraded Momenta Pharmaceuticals from Overweight to Equal-Weight.
-
La Jolla Pharmaceutical Company (NASDAQ: LJPC)
shares declined 3.5 percent to $32.79 after the company released Phase 3 results in the New England Journal of Medicine from a
study called ATHOS-3, which evaluated the company's therapy LJPC-501 for the treatment of patients with catecholamine resistant
hypotension (CRH).
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.